A Radiologist explains the role of PET-CT in molecular imaging. Irving, TX – June 15, 2020 –PET-CT is a nuclear imaging technique that combines positron emission tomography with computed tomography (CT). The technique allows doctors to visualize the metabolic activities of body cells. It uses a radiotracer to find cancer. Molecular imaging provides detailed images
PET scans are frequently used in the medical community and oncology. Today PET imaging is used in combination with computerized axial tomography for more accurate results. PET has been adopted in the treatment of lymphomas, where it’s often incorporated in treatment for Hodgkin’s and non-Hodgkin’s lymphoma. PET scans are used in staging and treating lymphomas
COVID-19 is often diagnosed through RT-PCR testing. Now some experts are arguing that CT scans can help to diagnose Covid-19. But others disagree with them. The covid-19 epidemic continues to spread all over the world, killing many people as nations strive to find cure or vaccination. Diagnosing people with SARS-CoV-2 early is key to combating
Patients with total metabolic response on FDG-PET scan should get consideration with complete response. Those with a partial response on a CT scan and a complete metabolic response on FDG-PET scan should be considered to have achieved a low risk for melanoma relapse and complete response. Patients with metastatic melanoma treated with anti-PD1 immune checkpoint
Irving, TX – May 14, 2020 – New technologies have been developed with the potential to identify cancer early and provide detailed information about a tumor’s biological activity. This helps doctors determine and plan an appropriate treatment for the patient. These molecular imaging techniques will show how aggressive a patient’s cancer is by looking at
A combination of imaging technology and a new drug can help light up lung cancer cells in the body to find hidden stray lung cancer cells. A preliminary study discovered that the new combination, known as intraoperative molecular imaging (IMI), helped surgeons to improve patient outcomes. The drug used in IMI is known as OTL38
PSMA positron emission tomography-computed tomography (PSMAPET-CT) was found to be 27% more accurate compared to conventional CT and bone scans. This was discovered in a phase 3 study conducted to detect distant metastases in high-risk prostate cancer patients. According to research, PSMA PET-CT can help stage men with high risk localized prostate cancer more accurately
Diagnosing and tracking tumors in patients with neuroendocrine cancer is quite challenging. However, a new pharmaceutical drug was approved for use with positron emission tomography (PET) to make rare tumors visible on medical imaging. Known as Gallium-68, or NETSpot, or Gallium Dotatate, the drug is used in PET-CT imaging of neuroendocrine tumors. PET scanning helps
Uses of PET Imaging in Oncology Irving, TX – April 15, 2020 –PET (positron emission tomography) uses radiotracers, a computer, and a special camera to evaluate tissue and organ functions in the body. It can detect changes at the cellular level and help to detect the onset of cancer. When combined with computed tomography, doctors
Positron Emission Tomography (PET) scans help to detect cancer sites by obtaining images of cell activity in the body. During the procedure, the patient is intravenously injected with a tracer containing sugar and radioactive material in small amounts. As cancer cells absorb more radioactive sugar, the tracer will light up. A special camera will scan